CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Up 112.6% in June

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 86,300 shares, an increase of 112.6% from the May 31st total of 40,600 shares. Based on an average daily trading volume, of 1,382,100 shares, the short-interest ratio is currently 0.1 days.

CV Sciences Price Performance

CV Sciences stock opened at $0.06 on Friday. The company’s 50-day moving average is $0.06 and its 200-day moving average is $0.04. The firm has a market capitalization of $10.60 million, a PE ratio of -2.93 and a beta of 0.60. CV Sciences has a fifty-two week low of $0.03 and a fifty-two week high of $0.10.

CV Sciences (OTCMKTS:CVSI) last announced its quarterly earnings results on Thursday, March 28th. The company reported ($0.01) earnings per share for the quarter. CV Sciences had a negative return on equity of 102.29% and a negative net margin of 20.38%. The business had revenue of $3.80 million for the quarter.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.